Skip to main content
SpringerLink
Log in

Adalimumab

Multi-dermatomal herpes zoster: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Agarwal M, et al. Use, safety and efficacy of ZRC 3197, a biosimilar candidate for reference adalimumab (HUMIRA) from a tertiary pediatric rheumatology centre in India. Arthritis and Rheumatology 68: 497-498, Oct 2016. Available from: URL: http://doi.org/10.1002/art.39977 [abstract] - India

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 1635, 19 (2017). https://doi.org/10.1007/s40278-017-25268-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-25268-4

Search

Navigation